Helius Enterprise Value vs Price to Sales Ratio Analysis
HSDT Stock | USD 4.82 0.16 3.21% |
Helius Medical financial indicator trend analysis is much more than just examining Helius Medical Techn latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Helius Medical Techn is a good investment. Please check the relationship between Helius Medical Enterprise Value and its Price To Sales Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Enterprise Value vs Price To Sales Ratio
Enterprise Value vs Price to Sales Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Helius Medical Techn Enterprise Value account and Price to Sales Ratio. At this time, the significance of the direction appears to have strong relationship.
The correlation between Helius Medical's Enterprise Value and Price to Sales Ratio is 0.7. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Price to Sales Ratio in the same time period over historical financial statements of Helius Medical Technologies, assuming nothing else is changed. The correlation between historical values of Helius Medical's Enterprise Value and Price to Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of Helius Medical Technologies are associated (or correlated) with its Price to Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price to Sales Ratio has no effect on the direction of Enterprise Value i.e., Helius Medical's Enterprise Value and Price to Sales Ratio go up and down completely randomly.
Correlation Coefficient | 0.7 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Enterprise Value
Enterprise Value (or EV) is usually referred to as Helius Medical theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Helius Medical Techn debt, but would also pocket its cash. Enterprise Value is more accurate representation of Helius Medical value than its market capitalization because it takes into account all of Helius Medical Technologies existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Price To Sales Ratio
Price to Sales Ratio is figured by comparing Helius Medical Techn stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Helius Medical sales, a figure that is much harder to manipulate than other Helius Medical Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Most indicators from Helius Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Helius Medical Techn current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. At this time, Helius Medical's Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 0.02 in 2024, despite the fact that Enterprise Value is likely to grow to (225.7 K).
Helius Medical fundamental ratios Correlations
Click cells to compare fundamentals
Helius Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Helius Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 15.1K | 24.0K | 49.1K | 269.9K | 607.9K | 577.5K | |
Total Assets | 10.3M | 6.5M | 14.1M | 17.3M | 7.7M | 9.9M | |
Total Current Liabilities | 3.8M | 2.4M | 2.7M | 2.0M | 1.9M | 1.8M | |
Total Stockholder Equity | 5.8M | 3.9M | 11.3M | 8.2M | 2.4M | 2.9M | |
Net Tangible Assets | 4.0M | 3.9M | 10.2M | 8.0M | 9.2M | 9.7M | |
Net Debt | (4.8M) | (3.2M) | (11.0M) | (14.4M) | (5.1M) | (5.4M) | |
Retained Earnings | (104.8M) | (118.9M) | (137.0M) | (151.1M) | (160.0M) | (152.0M) | |
Accounts Payable | 1.7M | 747K | 1.1M | 627K | 531K | 504.5K | |
Cash | 5.5M | 3.3M | 11.0M | 14.5M | 5.2M | 7.6M | |
Cash And Short Term Investments | 5.5M | 3.3M | 11.0M | 14.5M | 5.2M | 7.7M | |
Common Stock Total Equity | 52.2M | 26K | 31K | 1K | 900.0 | 855.0 | |
Liabilities And Stockholders Equity | 10.3M | 6.5M | 14.1M | 17.3M | 7.7M | 9.9M | |
Other Current Assets | 610K | 735K | 862K | 1.2M | 1.0M | 777.2K | |
Total Liab | 4.5M | 2.7M | 2.8M | 9.1M | 5.3M | 7.1M | |
Total Current Assets | 7.2M | 4.7M | 12.6M | 16.7M | 7.3M | 9.1M | |
Short Term Debt | 172K | 59K | 3K | 54K | 45K | 42.8K | |
Common Stock | 26K | 31K | 1K | 4K | 28K | 950.0 | |
Other Current Liab | 1.5M | 1.3M | 1.4M | 1.3M | 1.3M | 1.2M | |
Net Receivables | 574K | 230K | 251K | 343K | 637K | 401.2K | |
Non Current Liabilities Total | 710K | 252K | 193K | 7.1M | 3.5M | 2.6M | |
Capital Surpluse | 6.6M | 105.4M | 111.5M | 123.9M | 142.5M | 149.6M | |
Other Stockholder Equity | 111.5M | 123.9M | 149.4M | 159.6M | 163.0M | 91.3M | |
Accumulated Other Comprehensive Income | (902K) | (1.1M) | (1.1M) | (388K) | (673K) | (706.7K) | |
Non Current Assets Total | 3.1M | 1.9M | 1.5M | 590K | 394K | 374.3K | |
Property Plant And Equipment Net | 1.3M | 576K | 412K | 450K | 230K | 418.2K | |
Net Invested Capital | 5.8M | 3.9M | 11.3M | 8.2M | 2.4M | 2.2M | |
Property Plant And Equipment Gross | 1.3M | 576K | 412K | 450K | 589K | 631.4K | |
Net Working Capital | 3.4M | 2.3M | 9.9M | 14.7M | 5.6M | 5.8M | |
Property Plant Equipment | 1.3M | 486K | 412K | 450K | 517.5K | 612.2K | |
Inventory | 598K | 389K | 476K | 589K | 457K | 531.9K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Helius Stock analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.56) | Revenue Per Share 1.059 | Quarterly Revenue Growth (0.53) | Return On Assets (0.61) | Return On Equity (1.69) |
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.